1. Friedenstein A, Chailakhjan R, Lalykina K. The development of fibroblast colonies in monolayer cultures of guinea-pig bone marrow and spleen cells. Cell Prolif 1970;3:393-403. [ DOI:10.1111/j.1365-2184.1970.tb00347.x] 2. Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, Krause D, et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 2006;8:315-7. [ DOI:10.1080/14653240600855905] 3. Phinney DG, Prockop DJ. Concise review: mesenchymal stem/multipotent stromal cells: the state of transdifferentiation and modes of tissue repair-current views. Stem Cells 2007;25:2896-902. [ DOI:10.1634/stemcells.2007-0637] 4. Loebinger MR, Kyrtatos PG, Turmaine M, Price AN, Pankhurst Q, Lythgoe MF, et al. Magnetic resonance imaging of mesenchymal stem cells homing to pulmonary metastases using biocompatible magnetic nanoparticles. Cancer Res 2009;69:8862-7. [ DOI:10.1158/0008-5472.CAN-09-1912] 5. Sasportas LS, Kasmieh R, Wakimoto H, Hingtgen S, Van De Water JA, Mohapatra G, et al. Assessment of therapeutic efficacy and fate of engineered human mesenchymal stem cells for cancer therapy. Proc Natl Acad Sci U.S.A 2009;106:4822-7 . [ DOI:10.1073/pnas.0806647106] 6. Patel SA, Meyer JR, Greco SJ, Corcoran KE, Bryan M, Rameshwar P. Mesenchymal stem cells protect breast cancer cells through regulatory T cells: role of mesenchymal stem cell-derived TGF-β. J Immunol 2010;184:5885-94. [ DOI:10.4049/jimmunol.0903143] 7. Menon LG, Picinich S, Koneru R, Gao H, Lin SY, Koneru M, et al. Differential gene expression associated with migration of mesenchymal stem cells to conditioned medium from tumor cells or bone marrow cells. Stem Cells 2007;25:520-8. [ DOI:10.1634/stemcells.2006-0257] 8. Kidd S, Spaeth E, Dembinski JL, Dietrich M, Watson K, Klopp A, et al. Direct evidence of mesenchymal stem cell tropism for tumor and wounding microenvironments using in vivo bioluminescent imaging. Stem Cells 2009;27:2614-23. [ DOI:10.1002/stem.187] 9. Beckermann B, Kallifatidis G, Groth A, Frommhold D, Apel A, Mattern J, et al. VEGF expression by mesenchymal stem cells contributes to angiogenesis in pancreatic carcinoma. Br J Cancer 2008;99:622-31. [ DOI:10.1038/sj.bjc.6604508] 10. Block GJ, Ohkouchi S, Fung F, Frenkel J, Gregory C, Pochampally R, et al. Multipotent stromal cells are activated to reduce apoptosis in part by upregulation and secretion of stanniocalcin-1. Stem Cells 2009;27:670-81. [ DOI:10.1002/stem.20080742] 11. Barcellos-de-Souza P, Gori V, Bambi F, Chiarugi P. Tumor microenvironment: Bone marrow-mesenchymal stem cells as key players. Biochim Biophys Acta 2013;1836:321-35. [ DOI:10.1016/j.bbcan.2013.10.004] 12. Waterman RS, Tomchuck SL, Henkle SL, Betancourt AM. A new mesenchymal stem cell (MSC) paradigm: polarization into a pro-inflammatory MSC1 or an Immunosuppressive MSC2 phenotype. PloS One 2010;5:10088. [ DOI:10.1371/journal.pone.0010088] 13. Rüegger S, Großhans H. MicroRNA turnover: when, how, and why. Trends Biochem Sci 2012;37:436-46. [ DOI:10.1016/j.tibs.2012.07.002] 14. Xu L, Yang Bf, Ai J. MicroRNA transport: a new way in cell communication. J Cell Physiol 2013;228:1713-9. [ DOI:10.1002/jcp.24344] 15. Reddy KB. MicroRNA (miRNA) in cancer. Cancer Cell Int 2015;15:38. [ DOI:10.1186/s12935-015-0185-1] 16. Collino F, Bruno S, Deregibus MC, Tetta C, Camussi G. MicroRNAs and mesenchymal stem cells. Vitam Horm. 2011;87:291-320. [ DOI:10.1016/B978-0-12-386015-6.00033-0] 17. Chen Y, Gao D-Y, Huang L. In vivo delivery of miRNAs for cancer therapy: challenges and strategies. Adv Drug Deliv Rev 2015;81:128-41. [ DOI:10.1016/j.addr.2014.05.009] 18. Calin GA, Croce CM. MicroRNA signatures in human cancers. Nat Rev Cancer 2006;6:857-66. [ DOI:10.1038/nrc1997] 19. Gao J, Li N, Dong Y, Li S, Xu L, Li X, et al. miR-34a-5p suppresses colorectal cancer metastasis and predicts recurrence in patients with stage II/III colorectal cancer. Oncogene 2015;34:4142-52. [ DOI:10.1038/onc.2014.348] 20. Tomás HA, Rodrigues AF, Alves PM, Coroadinha AS. Lentiviral Gene Therapy Vectors: Challenges and Future Directions. London: InTechOpen; 2013. 21. Escors D, Breckpot K. Lentiviral vectors in gene therapy: their current status and future potential. Arch Immunol Ther Exp 2010;58:107-19. [ DOI:10.1007/s00005-010-0063-4]
|